Skip to main content
SpringerLink
Log in

The future of migraine treatment beyond sumatriptan

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

While the development of sumatriptan was a significant advance in the treatment of migraine, it is far from the end of the story. The latest clinical data on a number of new antimigraine drugs was presented at the tenth Migraine Trust international symposium on ‘Recent Advances in Migraine Research and Therapy’ [ London, UK; September 1994 ].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. David B Jack
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jack, D.B. The future of migraine treatment beyond sumatriptan. Inpharma Wkly. 957, 9–10 (1994). https://doi.org/10.2165/00128413-199409570-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199409570-00017

Keywords

Search

Navigation